Hypertrophic cardiomyopathy, also known as HCM or thick heart syndrome, is a genetic condition that causes your heart muscle ...

An acute necrotising myopathy is a distinct form of uncommon muscle disease characterised by the rapid advancement of ...

Danon disease is a rare but serious cardiomyopathy that drastically reduces life expectancy. Male patients infrequently live ...

Transthyretin Amyloid Cardiomyopathy Treatment Market is estimated to be valued at US$ 1.69 Bn in 2023, and is expected to exhibit a CAGR of 31.1% by 2030. Mr. Shah Coherent Market Insights Pvt. Ltd.

Hypertrophic cardiomyopathy (HCM) causes heart muscle thickening that may lead to obstructed blood flow. Symptoms include ...

This rate was significantly higher than the rates of statin treatment in age-matched groups of patients with PM, DM, or IBM. "We have identified a group of patients with a necrotizing myopathy and ...

A new 27-protein model accurately detects cardiomyopathy risk in childhood cancer survivors, aiding early intervention and ...

AI can enhance drug discovery, disease monitoring and public health efforts around pediatric health in New York. That's a ...

Rideout has arrhythmogenic right ventricular cardiomyopathy, or ARVC ... "The hope is, at some point, we will be able to ...

Medically reviewed by Yasmine S. Ali, MD, MSCI Cardiomegaly is the term used to describe an enlarged heart. It is most ...

Capricor Therapeutics, Inc.'s Deramiocel receives FDA Priority Review for DMD cardiomyopathy, with a decision by Aug. 2025.